Astute Medical

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases by identifying and validating protein biomarkers that can serve as the basis for novel diagnostic tests. The company focuses on acute conditions acquired in the community and hospital settings that require rapid diagnosis and risk assessment. Its current areas of interest include abdominal pain, acute coronary syndrome, cerebrovascular injury, kidney injury, and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Dr. Paul McPherson, former executives of Biosite Incorporated's management team. Biosite was a leading diagnostics company acquired by Inverness Medical Innovations for $1.7 billion in 2007. Hibberd worked at Biosite for 10 years, most recently serving as Senior Vice President of Corporate Development. Dr. McPherson spent 14 years at Biosite, most recently serving as Vice President of Research and Development.